Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Very early MS -- insights from MRI.
Acorda Announces Initiation of Phase 3 Clinical Trial for Dalfampridine in Post-Stroke Walking Deficits
Tumefactive MS lesions under fingolimod: A case report and literature review.
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
The autonomic balance predicts cardiac responses after the first dose of fingolimod.
SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains.
No MRI evidence of cortical lesions in neuromyelitis optica.
Enrollment complete for cannabinoid MS study
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study.
The translational biology of remyelination: Past, present, and future.
Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study.
Oral contraceptive use and clinical outcomes in patients with multiple sclerosis.
European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil.
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.
The role of complementary and alternative medicine in therapy of multiple sclerosis.
Targeting IRF4 in autoimmune diseases.
Humoral immune response to influenza vaccine in natalizumab-treated MS patients.
Trial watch: Chemotherapy with immunogenic cell death inducers.
Simvastatin in acute optic neuritis.
Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms.
A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project'
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.
Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.
A practical guide to the treatment of neuromyelitis optica.

Pages